Ospraie Ag Science LLC 4

Accession 0000899243-20-034269

CIK 0001441693other

View on SEC.gov Company Profile

Filed

Dec 16, 7:00 PM ET

Accepted

Dec 17, 2:39 PM ET

Size

17.3 KB

Accession

0000899243-20-034269

Insider Transaction Report

Form 4

Period: 2020-12-15

MARRONE BIO INNOVATIONS INCMBII

Anderson Dwight

Director10% OwnerOther

Transactions

Exercise/Conversion
Common Stock, $0.00001 par value
2020-12-15$0.75/sh+9,476,221$7,107,166→ 63,018,376 total
Exercise/Conversion
Warrant
2020-12-15−9,476,221→ 0 total
Exercise: $0.75From: 2020-04-29Exp: 2020-12-15→ Common Stock (9,476,221 underlying)

Ospraie Ag Science LLC

Director10% OwnerOther

Transactions

Exercise/Conversion
Warrant
2020-12-15−9,476,221→ 0 total
Exercise: $0.75From: 2020-04-29Exp: 2020-12-15→ Common Stock (9,476,221 underlying)
Exercise/Conversion
Common Stock, $0.00001 par value
2020-12-15$0.75/sh+9,476,221$7,107,166→ 63,018,376 total

Ospraie Management, LLC

Director10% OwnerOther

Transactions

Exercise/Conversion
Common Stock, $0.00001 par value
2020-12-15$0.75/sh+9,476,221$7,107,166→ 63,018,376 total
Exercise/Conversion
Warrant
2020-12-15−9,476,221→ 0 total
Exercise: $0.75From: 2020-04-29Exp: 2020-12-15→ Common Stock (9,476,221 underlying)

Ospraie Holding I, L.P.

Director10% OwnerOther

Transactions

Exercise/Conversion
Common Stock, $0.00001 par value
2020-12-15$0.75/sh+9,476,221$7,107,166→ 63,018,376 total
Exercise/Conversion
Warrant
2020-12-15−9,476,221→ 0 total
Exercise: $0.75From: 2020-04-29Exp: 2020-12-15→ Common Stock (9,476,221 underlying)

Ospraie Management, Inc.

Director10% OwnerOther

Transactions

Exercise/Conversion
Warrant
2020-12-15−9,476,221→ 0 total
Exercise: $0.75From: 2020-04-29Exp: 2020-12-15→ Common Stock (9,476,221 underlying)
Exercise/Conversion
Common Stock, $0.00001 par value
2020-12-15$0.75/sh+9,476,221$7,107,166→ 63,018,376 total

Footnotes (3)

[F1]On December 15, 2020, Ospraie Ag Science LLC ("Ospraie LLC") exercised warrants to purchase Common Stock of Marrone Bio Innovations, Inc. (the "Issuer") and purchased the 9,476,221 shares of Issuer Common Stock underlying such warrants.
[F2]Ospraie Management, LLC ("Ospraie Management") is the investment manager of Ospraie LLC and has been delegated voting and investment power and thus beneficial ownership of the shares of Common Stock of the Issuer and warrants to purchase shares of Common Stock of the Issuer held by Ospraie LLC. Ospraie Holding I, LP ("Ospraie Holding") may be deemed to beneficially own the shares of Common Stock of the Issuer and warrants to purchase shares of Common Stock of the Issuer held by Ospraie LLC as the managing member of Ospraie Management. Ospraie Management, Inc. ("Ospraie Inc.") may be deemed to beneficially own the shares of Common Stock of the Issuer and warrants to purchase Common Stock of the Issuer held by Ospraie LLC as the general partner of Ospraie Holding.
[F3](Continued from footnote 2) Dwight Anderson may be deemed to beneficially own the shares of Common Stock of the Issuer and warrants to purchase Common Stock of the Issuer held by Ospraie LLC as the Managing Principal of Ospraie Management, the sole owner of Ospraie Inc. and the sole managing member of Ospraie LLC. Each Reporting Person disclaims beneficial ownership of the securities reported herein except to the extent of his or its pecuniary interest therein, if any.

Documents

2 files

Issuer

MARRONE BIO INNOVATIONS INC

CIK 0001441693

→

Entity typeother

IncorporatedDE

Related Parties

filerCIK 0001730557

Filing Metadata

Form type: 4
Filed: Dec 16, 7:00 PM ET
Accepted: Dec 17, 2:39 PM ET
Size: 17.3 KB

View on SEC.gov